Login
China Healthcare
- Pininvest Analysis
No one doubts health care in China is becoming an ever bigger story and no one will be surprised to see the Chinese authorities focus doggedly on strengthening the country’s pharmaceutical expertise
With most of the pharmaceutical businesses quoted on Chinese stock markets, American investors may be advised to refer to our theme of US listed companies as informative – but partial – guidelines regarding some of the Chinese health care trends
- Not all the OTC-listed companies appear to be actively traded, though successfully introduced on the Chinese market
- High valuations may in many cases reflect a tendency of the Chinese investors to ‘overshoot’ in a spurt of optimism
The overall growth perspectives, and the will to ensure Chinese companies are the immediate beneficiaries, are unquestionable – foreign providers, such as Novo Nordisk of Denmark [asset ticker="NVO" mnemonic="NYSE"] in the diabetes market, are well aware of the challenge
China Healthcare • Updated:
| Name | Ticker | Exchange | Sector | Industry | Currency | Cur.Price | Mkt.Cap | Perf. | Momentum | Vol. | Risk Contrib. | MDD |
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alibaba Health Information Technology | ALBHF | OTC | Health Care | Healthcare Supply Chain & InfoTech | USD | 1.70 | - | -37.0 % | Sharp Down | 63 % | 10 % | -65 % |
|
|
| BeiGene | BGNE | NASDAQ | Health Care | Gene Editing - Cell Therapies | USD | 316.59 | 29 B | 51.5 % | Weak Down | 53 % | 8 % | -30 % |
|
|
| Cellular Biomedicine | CBMG | NASDAQ | Health Care | Biopharmaceuticals | USD | 19.75 | 384 M | 50.0 % | Weak Up | 35 % | 1 % | -11 % |
|
|
| Concord Medical Services | CCM | NYSE | Health Care | Healthcare Facilities & Services | USD | 2.98 | 129 M | 67.4 % | Neutral | 140 % | 17 % | -54 % |
|
|
| CSPC Pharmaceutical Group | CHJTF | OTC | Health Care | Drug Manufacturers - Diversified | USD | 1.42 | - | 11.3 % | Strong Up | 75 % | 3 % | -49 % |
|
|
| Genscript Biotech | GNNSF | OTC | Health Care | Biopharmaceuticals | USD | 4.35 | - | 97.9 % | Weak Down | 86 % | 8 % | -34 % |
|
|
| Guangzhou Baiyunshan Pharmaceutical Holdings | GZPHF | OTC | Health Care | Drug Manufacturers - Diversified | USD | 3.14 | - | -14.0 % | Strong Up | 30 % | 1 % | -34 % |
|
|
| Hutchison China MediTech | HCM | NASDAQ | Health Care | Drug Manufacturers -Specialty Pharma | USD | 42.05 | 6.1 B | 55.1 % | Strong Up | 53 % | 6 % | -36 % |
|
|
| Novo Nordisk | NVO | NYSE | Health Care | Diabetes | USD | 92.60 | 218 B | 42.5 % | Strong Up | 22 % | 2 % | -13 % |
|
|
| Shandong Weigao Group Medical | SHWGY | OTC | Health Care | Medical Consumables & Intermediates | USD | 7.35 | - | -22.1 % | Sharp Down | 48 % | 5 % | -41 % |
|
|
| Shanghai Fosun Pharmaceutical | SFOSF | OTC | Health Care | Drug Manufacturers - Diversified | USD | 7.83 | - | 67.7 % | Neutral | 64 % | 6 % | -17 % |
|
|
| Shanghai Pharmaceuticals | SHPMY | OTC | Health Care | Drug Manufacturers - Diversified | USD | 10.51 | - | 18.1 % | Neutral | 49 % | 3 % | -28 % |
|
|
| Sino Biopharmaceutical | SBMFF | OTC | Health Care | Drug Manufacturers - Diversified | USD | 0.83 | - | -34.2 % | Sharp Down | 54 % | 4 % | -37 % |
|
|
| Sinopharm Group | SHTDF | OTC | Health Care | Drug Manufacturers - Diversified | USD | 2.65 | - | 8.2 % | Sharp Down | 46 % | 4 % | -25 % |
|
|
| Tong Ren Tang Technologies | TGRNF | OTC | Health Care | Drug Manufacturers - Diversified | USD | 0.62 | - | -22.5 % | Neutral | 29 % | 1 % | -26 % |
|
|
| WuXi Biologics (Cayman) | WXXWY | OTC | Health Care | Medical Laboratories & Research | USD | 31.32 | - | 128.7 % | Weak Down | 89 % | 13 % | -53 % |
|
|
| Zai Lab | ZLAB | NASDAQ | Health Care | Oncology | USD | 144.61 | 13 B | 90.0 % | Weak Down | 63 % | 10 % | -39 % |
|